BMRNNasdaqPharmaceutical PreparationsFiscal year ends December 31
BIOMARIN PHARMACEUTICAL INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$54.67−0.01 (-0.02%)
Close on Oct 19, 2026
- Market cap
- $10.63B
- P/E (TTM)
- 143.9
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
100.0%
196M of 194M shares
Institutional holders
564
87 new, 77 sold out
Net institutional buying
13M
In Q2 2026
Insider trades, 12 months
0 buys · 5 sales
Net sold $4.32M
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 17,560,751 | 9.10% | 13G (passive) amendment | Dec 31, 2025 |
| Primecap Management Co/Ca/ | 15,795,383 | 8.24% | 13G (passive) amendment | Jun 30, 2025 |
| Dodge & Cox | 13,994,063 | 7.40% | 13G (passive) amendment | Dec 31, 2023 |
| Viking Global Investors LP | 12,288,611 | 6.40% | 13G (passive) amendment | Jun 30, 2025 |
| Vanguard Capital Management | 10,113,219 | 5.25% | 13G (passive) | Mar 31, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of BMRN | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 20,445,212 | 10.56% | $1.17B | +626,911 | 0.02% |
| Dodge & Cox | 14,844,930 | 7.67% | $849.43M | +283,171 | 0.44% |
| Primecap Management Co/Ca/ | 14,190,183 | 7.33% | $811.96M | −3,822 | 0.48% |
| Vanguard Capital Management LLC | 8,743,633 | 4.52% | $500.31M | +100,469 | 0.01% |
| Vanguard Portfolio Management LLC | 8,648,678 | 4.47% | $494.88M | +350,203 | 0.02% |
| Norges Bank | 8,207,954 | 4.24% | $469.66M | New | 0.05% |
| State Street Corp | 7,800,959 | 4.03% | $446.37M | +505,880 | 0.01% |
| Viking Global Investors LP | 7,616,563 | 3.93% | $435.82M | +554,486 | 1.24% |
| Vestal Point Capital, LP | 6,025,000 | 3.11% | $344.75M | +2,450,000 | 8.06% |
| Aqr Capital Management LLC | 5,699,541 | 2.94% | $322.54M | −1,977,000 | 0.11% |
| FMR LLC | 4,822,893 | 2.49% | $275.97M | +1,255,862 | 0.01% |
| Dimensional Fund Advisors LP | 4,075,714 | 2.11% | $233.22M | +272,784 | 0.04% |
| Geode Capital Management, LLC | 3,911,794 | 2.02% | $223.89M | +92,353 | 0.01% |
| Assenagon Asset Management S.A. | 3,524,172 | 1.82% | $201.65M | +1,603,514 | 0.13% |
| Capital Research Global Investors | 3,504,387 | 1.81% | $200.52M | +13,001 | 0.03% |
| Deep Track Capital, LP | 3,307,481 | 1.71% | $189.25M | +2,157,481 | 2.75% |
| Millennium Management LLC | 2,071,816 | 1.07% | $118.55M | −938,492 | 0.04% |
| Charles Schwab Investment Management Inc | 1,616,020 | 0.83% | $92.47M | +28,337 | 0.01% |
| First Trust Advisors LP | 1,606,273 | 0.83% | $91.91M | −66,218 | 0.05% |
| Northern Trust Corp | 1,558,104 | 0.80% | $89.15M | −28,280 | 0.01% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 564 | 196M | 100.0% | 87 / 204 | 196 / 77 | 33M | 19M |
| Q1 2026 | 559 | 184M | 94.9% | 92 / 213 | 164 / 67 | 42M | 27M |
| Q4 2025 | 539 | 189M | 97.5% | 102 / 168 | 210 / 127 | 36M | 27M |
| Q3 2025 | 577 | 180M | 93.1% | 75 / 225 | 201 / 74 | 17M | 22M |
| Q2 2025 | 582 | 185M | 95.6% | 86 / 243 | 186 / 81 | 28M | 29M |
| Q1 2025 | 584 | 186M | 96.2% | 100 / 242 | 176 / 55 | 19M | 15M |
| Q4 2024 | 544 | 184M | 95.0% | 91 / 202 | 184 / 92 | 18M | 18M |
| Q3 2024 | 555 | 183M | 94.7% | 87 / 198 | 198 / 86 | 38M | 20M |
| Q2 2024 | 560 | 188M | 97.1% | 88 / 194 | 198 / 80 | 30M | 32M |
| Q1 2024 | 559 | 191M | 98.9% | 67 / 196 | 205 / 53 | 20M | 19M |
| Q4 2023 | 548 | 190M | 98.0% | 86 / 180 | 204 / 50 | 24M | 17M |
| Q3 2023 | 520 | 183M | 94.3% | 43 / 191 | 192 / 76 | 19M | 13M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of BMRN | Value | % of fund | As of |
|---|---|---|---|---|---|
| Dodge & Cox Stock Fund | 9,769,625 | 5.05% | $559.02M | 0.47% | Jun 30, 2026 |
| iShares Core S&P Mid-Cap ETF | 6,614,631 | 3.42% | $378.49M | 0.30% | Jun 30, 2026 |
| Vanguard Total Stock Market Index Fund | 6,142,022 | 3.17% | $351.45M | 0.02% | Jun 30, 2026 |
| Vanguard Capital Opportunity Fund | 5,168,345 | 2.67% | $295.73M | 0.90% | Jun 30, 2026 |
| Vanguard Primecap Fund | 4,969,450 | 2.57% | $284.35M | 0.30% | Jun 30, 2026 |
| Vanguard Small-Cap Index Fund | 4,434,241 | 2.29% | $253.73M | 0.13% | Jun 30, 2026 |
| Capital World Growth & Income Fund | 2,576,251 | 1.33% | $147.59M | 0.09% | May 31, 2026 |
| Vanguard Small-Cap Growth Index Fund | 2,554,018 | 1.32% | $146.14M | 0.31% | Jun 30, 2026 |
| Fidelity Contrafund | 2,529,010 | 1.31% | $144.71M | 0.08% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 2,216,774 | 1.15% | $126.84M | 0.13% | Jun 30, 2026 |
| State Street(R) SPDR(R) S&P(R) Biotech ETF | 1,772,667 | 0.92% | $101.43M | 0.94% | Jun 30, 2026 |
| PRIMECAP Odyssey Aggressive Growth Fund | 1,412,415 | 0.73% | $84.77M | 1.15% | Jul 31, 2026 |
| First Trust NYSE Arca Biotechnology Index Fund | 1,391,830 | 0.72% | $79.64M | 2.83% | Jun 30, 2026 |
| iShares Biotechnology ETF | 1,348,623 | 0.70% | $77.17M | 0.85% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 984,215 | 0.51% | $56.39M | 0.13% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Alexander Hardy | Chief Executive Officer, Director | 214,635 | 0.11% | Mar 19, 2026 |
| George Eric Davis | EVP, Chief Legal Officer | 61,003 | 0.03% | Sep 3, 2026 |
| Cristin Hubbard | EVP, Chief Commercial Officer | 42,472 | 0.02% | May 21, 2026 |
| Gregory R. Friberg | EVP, Chief R&D Officer | 51,818 | 0.03% | May 11, 2026 |
| Charles Greg Guyer | EVP, Chief Technical Officer | 84,140 | 0.04% | Mar 19, 2026 |
| Brian Mueller | EVP, Chief Financial Officer | 123,314 | 0.06% | Mar 19, 2026 |
| Rashmi Virendra Ramchandani | VP, Chief Accounting Officer | 25,610 | 0.01% | Jan 22, 2026 |
| Erin Burkhart | GVP, Chief Accounting Officer | 14,173 | 0.01% | May 20, 2025 |
| Robert M. Plenge | Director | 6,140 | 0.00% | Sep 14, 2026 |
| Mark J. Enyedy | Director | 21,040 | 0.01% | Jun 4, 2026 |
| Athena Countouriotis | Director | 21,040 | 0.01% | Jun 4, 2026 |
| Maykin Ho | Director | 35,500 | 0.02% | Jun 4, 2026 |
| Willard H. Dere | Director | 46,440 | 0.02% | Jun 4, 2026 |
| Barbara W. Bodem | Director | 21,045 | 0.01% | Jun 4, 2026 |
| Robert J. Hombach | Director | 49,360 | 0.03% | Jun 4, 2026 |
| Elizabeth M. Anderson | Director | 41,940 | 0.02% | Jun 4, 2026 |
| Timothy P. Walbert | Director | 17,686 | 0.01% | Jun 4, 2026 |
| Ian T. Clark | Director | 14,490 | 0.01% | Jun 4, 2026 |
| Richard A. Meier | Director | 126,926 | 0.07% | Feb 13, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Robert M. Plenge Director | Sep 10, 2026 | Award | +6,140 | – | – | 6,140 |
| George Eric Davis EVP, Chief Legal Officer | Sep 2, 2026 | Sale | −17,557 | $66.28 | $1.16M | 61,003 |
| Timothy P. Walbert Director | Jun 2, 2026 | Award | +7,490 | – | – | 17,270 |
| Maykin Ho Director | Jun 2, 2026 | Award | +7,490 | – | – | 35,500 |
| Athena Countouriotis Director | Jun 2, 2026 | Award | +7,490 | – | – | 21,040 |
| Willard H. Dere Director | Jun 2, 2026 | Award | +7,490 | – | – | 46,440 |
| Elizabeth M. Anderson Director | Jun 2, 2026 | Award | +7,490 | – | – | 41,940 |
| Ian T. Clark Director | Jun 2, 2026 | Award | +7,490 | – | – | 14,490 |
| Mark J. Enyedy Director | Jun 2, 2026 | Award | +7,490 | – | – | 21,040 |
| Robert J. Hombach Director | Jun 2, 2026 | Award | +7,490 | – | – | 49,360 |
| Barbara W. Bodem Director | Jun 2, 2026 | Award | +7,490 | – | – | 21,045 |
| Cristin Hubbard EVP, Chief Commercial Officer | May 20, 2026 | Tax withholding | −2,318 | $50.20 | $116.36K | 42,472 |
| Gregory R. Friberg EVP, Chief R&D Officer | May 7, 2026 | Sale | −3,281 | $53.85 | $176.68K | 51,818 |
| George Eric Davis EVP, Chief Legal Officer | Mar 18, 2026 | Tax withholding | −1,273 | $56.05 | $71.35K | 78,560 |
| Charles Greg Guyer EVP, Chief Technical Officer | Mar 17, 2026 | Tax withholding | −1,693 | $56.05 | $94.89K | 84,140 |
| Alexander Hardy Chief Executive Officer, Director | Mar 17, 2026 | Tax withholding | −4,252 | $56.05 | $238.32K | 214,635 |
| Brian Mueller EVP, Chief Financial Officer | Mar 17, 2026 | Tax withholding | −2,117 | $56.05 | $118.66K | 123,314 |
| Gregory R. Friberg EVP, Chief R&D Officer | Mar 17, 2026 | Tax withholding | −1,629 | $56.05 | $91.31K | 55,099 |
| Cristin Hubbard EVP, Chief Commercial Officer | Mar 17, 2026 | Tax withholding | −1,245 | $56.05 | $69.78K | 44,790 |
| Gregory R. Friberg EVP, Chief R&D Officer | Mar 16, 2026 | Award | +19,150 | – | – | 56,728 |
| Cristin Hubbard EVP, Chief Commercial Officer | Mar 16, 2026 | Award | +15,410 | – | – | 46,035 |
| Brian Mueller EVP, Chief Financial Officer | Mar 16, 2026 | Award | +18,740 | – | – | 125,431 |
| Charles Greg Guyer EVP, Chief Technical Officer | Mar 16, 2026 | Award | +14,990 | – | – | 85,833 |
| George Eric Davis EVP, Chief Legal Officer | Mar 16, 2026 | Tax withholding | −7,177 | $58.51 | $419.93K | 65,263 |
| George Eric Davis EVP, Chief Legal Officer | Mar 16, 2026 | Award | +14,570 | – | – | 79,833 |
| Alexander Hardy Chief Executive Officer, Director | Mar 16, 2026 | Award | +62,440 | – | – | 218,887 |
| Brian Mueller EVP, Chief Financial Officer | Mar 13, 2026 | Tax withholding | −9,945 | $58.51 | $581.88K | 106,691 |
| Charles Greg Guyer EVP, Chief Technical Officer | Mar 13, 2026 | Tax withholding | −9,109 | $58.51 | $532.97K | 70,843 |
| Alexander Hardy Chief Executive Officer, Director | Mar 13, 2026 | Tax withholding | −2,941 | $58.51 | $172.08K | 156,447 |
| Charles Greg Guyer EVP, Chief Technical Officer | Mar 11, 2026 | Sale | −16,486 | $60.46 | $996.74K | 79,953 |
| Gregory R. Friberg EVP, Chief R&D Officer | Feb 26, 2026 | Sale | −6,326 | $60.38 | $381.96K | 37,578 |
| George Eric Davis EVP, Chief Legal Officer | Feb 26, 2026 | Sale | −26,061 | $61.36 | $1.60M | 72,453 |
| Brian Mueller EVP, Chief Financial Officer | Feb 25, 2026 | Award | +6,683 | – | – | 106,839 |
| Brian Mueller EVP, Chief Financial Officer | Feb 25, 2026 | Award | +7,230 | – | – | 114,069 |
| Brian Mueller EVP, Chief Financial Officer | Feb 25, 2026 | Award | +2,569 | – | – | 116,638 |
| George Eric Davis EVP, Chief Legal Officer | Feb 25, 2026 | Award | +6,177 | – | – | 89,467 |
| George Eric Davis EVP, Chief Legal Officer | Feb 25, 2026 | Award | +6,675 | – | – | 96,142 |
| George Eric Davis EVP, Chief Legal Officer | Feb 25, 2026 | Award | +2,372 | – | – | 98,514 |
| Charles Greg Guyer EVP, Chief Technical Officer | Feb 25, 2026 | Award | +6,176 | – | – | 87,393 |
| Charles Greg Guyer EVP, Chief Technical Officer | Feb 25, 2026 | Award | +6,675 | – | – | 94,068 |
| Charles Greg Guyer EVP, Chief Technical Officer | Feb 25, 2026 | Award | +2,371 | – | – | 96,439 |
| Rashmi Virendra Ramchandani VP, Chief Accounting Officer | Jan 20, 2026 | Award | +7,070 | – | – | 25,610 |
| Rashmi Virendra Ramchandani VP, Chief Accounting Officer | Jan 20, 2026 | Award | +18,540 | – | – | 18,540 |
| Richard A. Meier Director | Dec 30, 2025 | Gift | −500 | – | – | 126,926 |
| Alexander Hardy Chief Executive Officer, Director | Dec 1, 2025 | Tax withholding | −16,570 | $55.03 | $911.85K | 159,388 |
| Charles Greg Guyer EVP, Chief Technical Officer | Oct 31, 2025 | Award | +62 | $45.54 | $2.82K | 81,217 |
| Cristin Hubbard EVP, Chief Commercial Officer | Oct 31, 2025 | Award | +80 | $45.54 | $3.64K | 30,625 |
| Gregory R. Friberg EVP, Chief R&D Officer | Oct 31, 2025 | Award | +398 | $45.54 | $18.12K | 43,904 |
| Gregory R. Friberg EVP, Chief R&D Officer | Sep 30, 2025 | Tax withholding | −3,304 | $54.16 | $178.94K | 43,506 |
| Ian T. Clark Director | Aug 1, 2025 | Award | +7,000 | – | – | 7,000 |
| Barbara W. Bodem Director | May 20, 2025 | Award | +6,650 | – | – | 13,555 |
| Richard A. Meier Director | May 20, 2025 | Award | +6,650 | – | – | 127,426 |
| Mark J. Enyedy Director | May 20, 2025 | Award | +6,650 | – | – | 13,550 |
| Maykin Ho Director | May 20, 2025 | Award | +6,650 | – | – | 28,010 |
| Timothy P. Walbert Director | May 20, 2025 | Award | +6,650 | – | – | 9,780 |
| Elizabeth M. Anderson Director | May 20, 2025 | Award | +6,650 | – | – | 34,450 |
| Athena Countouriotis Director | May 20, 2025 | Award | +6,650 | – | – | 13,550 |
| Cristin Hubbard EVP, Chief Commercial Officer | May 20, 2025 | Tax withholding | −2,155 | $59.93 | $129.15K | 30,545 |
| Willard H. Dere Director | May 20, 2025 | Award | +6,650 | – | – | 38,950 |
| Robert J. Hombach Director | May 20, 2025 | Award | +6,650 | – | – | 41,870 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| George Eric Davis Officer | Sep 2, 2026 | 17,557 | $1.16M | Sep 2, 2026 | Restricted Stock Vesting |
| Gregory R. Friberg Officer | May 7, 2026 | 3,281 | $176.68K | May 7, 2026 | Restricted Stock Vesting |
| Charles Greg Guyer Officer | Mar 11, 2026 | 16,486 | $996.75K | Mar 11, 2026 | Restricted Stock Vesting |
| Gregory R. Friberg Officer | Feb 26, 2026 | 6,326 | $381.94K | Feb 26, 2026 | Restricted Stock Vesting |
| George Eric Davis Officer | Feb 26, 2026 | 26,061 | $1.60M | Feb 26, 2026 | Stock Option Exercise |
| Erin Burkhart Officer | May 20, 2025 | 1,786 | $105.93K | May 20, 2025 | Restricted Stock Vesting |
| Cristin Hubbard Officer | May 2, 2025 | 273 | $17.72K | May 2, 2025 | ESPP Purchase |
| Erin Burkhart Officer | Mar 19, 2025 | 1,295 | $92.62K | Mar 19, 2025 | Restricted Stock Vesting |
| Charles Greg Guyer Officer | Mar 6, 2025 | 7,034 | $501.36K | Mar 6, 2025 | Restricted Stock Vesting |
| Erin Burkhart Officer | Feb 24, 2025 | 1,344 | $91.90K | Feb 24, 2025 | Restricted Stock Vesting |
| Charles Greg Guyer Officer | Nov 12, 2024 | 5,278 | $350.32K | Nov 12, 2024 | Restricted Stock Vesting |
| Erin Burkhart Officer | Aug 13, 2024 | 714 | $64.26K | Aug 13, 2024 | Restricted Stock Vesting |
| Jeffrey Robert Ajer Officer | Jun 4, 2024 | 5,000 | $384.00K | Jun 4, 2024 | Restricted Stock Vesting |
| Jean Jacques Bienaime Former Director | May 31, 2024 | 31,000 | $2.31M | May 31, 2024 | Option Granted - 06/04/2014 |
| Brian Mueller Officer | May 30, 2024 | 5,000 | $375.95K | May 30, 2024 | Option Granted - 06/04/2014 |